These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 642026)
1. Biochemical parameters of resistance of an adriamycin-resistant subline of P388 leukemia to emetine, an inhibitor of protein synthesis. Chitnis MP; Johnson RK J Natl Cancer Inst; 1978 May; 60(5):1049-54. PubMed ID: 642026 [TBL] [Abstract][Full Text] [Related]
2. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia. Johnson RK; Chitnis MP; Embrey WM; Gregory EB Cancer Treat Rep; 1978 Oct; 62(10):1535-47. PubMed ID: 709555 [TBL] [Abstract][Full Text] [Related]
3. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Goldenberg GJ; Wang H; Blair GW Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020 [TBL] [Abstract][Full Text] [Related]
4. Circumvention of adriamycin resistance: effect of 2-methyl-1,4-naphthoquinone (vitamin K3) on drug cytotoxicity in sensitive and MDR P388 leukemia cells. Parekh HK; Mansuri-Torshizi H; Srivastava TS; Chitnis MP Cancer Lett; 1992 Jan; 61(2):147-56. PubMed ID: 1730138 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of quinidine effect on the antitumor activity of adriamycin and mitoxantrone in adriamycin-sensitive and -resistant P388 leukemia cells. Parekh H; Chitnis M Sel Cancer Ther; 1990; 6(2):93-102. PubMed ID: 2367755 [TBL] [Abstract][Full Text] [Related]
6. Modulation of in vitro chemosensitivity by extracellular Ca++ in adriamycin sensitive and resistant P388 leukemic cells. Adwankar MK; Chitnis MP Neoplasma; 1990; 37(1):31-6. PubMed ID: 2320178 [TBL] [Abstract][Full Text] [Related]
7. Murine splenocyte migration inhibition assay I. Detection of differential responses to murine leukemia P388 and its adriamycin-resistant subline P388/ADR. Nori M; Gothoskar BP Neoplasma; 1983; 30(3):287-93. PubMed ID: 6223231 [TBL] [Abstract][Full Text] [Related]
8. Differential effect of clofibrate on adriamycin cytotoxicity in P388 murine leukemia cells sensitive and resistant to adriamycin. Chitnis M; Parekh H; Satyamoorthy K Tumori; 1989 Apr; 75(2):100-5. PubMed ID: 2741213 [TBL] [Abstract][Full Text] [Related]
9. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells. Ganapathi R; Reiter W; Krishan A J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267 [TBL] [Abstract][Full Text] [Related]
10. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin]. Lepri E; Menconi E; Barzi AM Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1369-75. PubMed ID: 6477749 [TBL] [Abstract][Full Text] [Related]
11. Antineoplastic activity of mitoxantrone and its biological interactions in parental and multidrug resistant subline of P388 murine leukemia cells. Chavan S; Parekh H; Chitnis M Neoplasma; 1992; 39(1):49-57. PubMed ID: 1528304 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine. Ganapathi R; Grabowski D Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140 [TBL] [Abstract][Full Text] [Related]
13. Differential effect of collaterally sensitive antimetabolites on P388 murine leukemia sensitive and resistant to adriamycin in vitro. Satyamoorthy K; Deshpande SS; Chitnis MP Neoplasma; 1989; 36(6):673-83. PubMed ID: 2515459 [TBL] [Abstract][Full Text] [Related]
14. Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine. Wilkoff LJ; Dulmadge DA; Laster WR; Griswold DP Cancer Chemother Pharmacol; 1989; 23(3):145-50. PubMed ID: 2924372 [TBL] [Abstract][Full Text] [Related]
15. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875 [TBL] [Abstract][Full Text] [Related]
16. Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and -resistant P388 cells. Streeter DG; Johl JS; Gordon GR; Peters JH Cancer Chemother Pharmacol; 1986; 16(3):247-52. PubMed ID: 3457646 [TBL] [Abstract][Full Text] [Related]
17. Modulation of in vitro response to adriamycin by verapamil in murine P388 leukaemia, Ehrlich ascites carcinoma and sarcoma 180. Pradhan SG; Chitnis MP; Basrur VS; Tantri SK Eur J Cancer Clin Oncol; 1987 Apr; 23(4):437-42. PubMed ID: 3609108 [TBL] [Abstract][Full Text] [Related]
18. Selenium (Se) cytotoxicity in drug sensitive and drug resistant murine tumour. Shallom J; Juvekar A; Chitnis M Cancer Biother; 1995; 10(3):243-8. PubMed ID: 8547963 [TBL] [Abstract][Full Text] [Related]
19. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Inaba M; Kobayashi H; Sakurai Y; Johnson RK Cancer Res; 1979 Jun; 39(6 Pt 1):2200-3. PubMed ID: 445418 [TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein expression and modulation of cell-membrane morphology in adriamycin-resistant P388 leukemia cells. Radel S; Fredericks W; Mayhew E; Baker R Cancer Chemother Pharmacol; 1990; 25(4):241-6. PubMed ID: 1967228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]